Xeraya Capital
Xeraya Capital is a venture capital and private equity firm focused on life sciences investments. The firm aims to drive global value while emphasizing local benefits, supporting innovations that improve lives and enhance global sustainability. Xeraya Capital invests in companies that develop medical innovations, biotechnological advancements, and sustainable health solutions, with a commitment to ethical business practices and strategic partnerships.
Xeraya Capital
26.03–26.08, G Tower, #199 Jalan Tun Razak, KL
Portfolio
Liquidia is involved in medical technologies, focusing on innovative solutions.
#Medical Technologies
Foghorn Therapeutics is focused on drug development and pharmaceutical biotechnology.
#Pharmaceutical Biotechnology
ViewRay specializes in medical technologies, particularly in imaging and radiation therapy.
#Medical Technologies
Iconic Therapeutics focuses on pharmaceutical biotechnology and drug development.
#Pharmaceutical Biotechnology
Congenica is involved in medical technologies, with a focus on genomic analysis.
#Medical Technologies
InterVenn Biosciences specializes in diagnostics and medical technologies.
#Medical Technologies
LanzaTech focuses on sustainability-driven platforms and biorenewables.
#Biorenewables & Others
Aria CV is involved in medical technologies, particularly in cardiovascular innovations.
#Medical Technologies
Mitralign focuses on medical technologies related to cardiovascular treatments.
#Medical Technologies
Greenlight Biosciences is involved in biorenewables and sustainable solutions.
#Biorenewables & Others
Acutus Medical specializes in arrhythmia care and electrophysiology technologies.
#Medical Technologies
Key People
CEO of Xeraya Capital
Senior Vice President, Investments